Afatinib (A) Followed By a + Paclitaxel (P) or Investigator'S Choice of Single-Agent Chemotherapy (Ic) in Patients (Pts) with Advanced Squamous Cell Carcinoma (Scc) of the Lung: Subgroup Analysis of Lux-Lung 5 (Ll5)
Year: 2014
Type: article
Source: Annals of Oncology
Authors: K. Park, J. Kim, M. Schuler, D. Planchard, F. De Marinis, Y. Chen, C. Zhou, J. Bennouna, L. Xiaoqing, J. Feng, P. Bidoli, J. Strausz, C. Chouaid, M. Huang, L. Ho, B. Wang, V. Chand, J. Yang
Institutions: Samsung Medical Center, Yonsei University, Yonsei University Health System, University of Duisburg-Essen, Institut Gustave Roussy, European Institute of Oncology, Taipei Veterans General Hospital, Taipei Medical University, Shanghai Pulmonary Hospital, 307th Hospital of Chinese People’s Liberation Army, Jiangsu Cancer Hospital, Azienda Ospedaliera San Gerardo, Hôpital Intercommunal de Créteil, Kaohsiung Medical University, Tri-Service General Hospital, Boehringer Ingelheim (United States), National Taiwan University Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2128911386